$CTSH
COGNIZANT TECHNOLOGY SOLUTIONS CORP

2022 Q1 Form 10-Q Financial Statement

#000105829022000113 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $4.826B $4.401B
YoY Change 9.66% 4.17%
Cost Of Revenue $3.097B $2.764B
YoY Change 12.05% 0.84%
Gross Profit $1.729B $1.637B
YoY Change 5.62% 10.31%
Gross Profit Margin 35.83% 37.2%
Selling, General & Admin $862.0M $827.0M
YoY Change 4.23% 16.32%
% of Gross Profit 49.86% 50.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $143.0M $141.0M
YoY Change 1.42% 3.68%
% of Gross Profit 8.27% 8.61%
Operating Expenses $862.0M $827.0M
YoY Change 4.23% 16.32%
Operating Profit $724.0M $669.0M
YoY Change 8.22% 15.54%
Interest Expense $2.000M $2.000M
YoY Change 0.0% -66.67%
% of Operating Profit 0.28% 0.3%
Other Income/Expense, Net $5.000M -$4.000M
YoY Change -225.0% -94.2%
Pretax Income $729.0M $665.0M
YoY Change 9.62% 30.39%
Income Tax $170.0M $160.0M
% Of Pretax Income 23.32% 24.06%
Net Earnings $563.0M $505.0M
YoY Change 11.49% 37.6%
Net Earnings / Revenue 11.67% 11.47%
Basic Earnings Per Share $1.07 $0.95
Diluted Earnings Per Share $1.07 $0.95
COMMON SHARES
Basic Shares Outstanding 524.0M shares 530.0M shares
Diluted Shares Outstanding 525.0M shares 531.0M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.319B $2.158B
YoY Change 7.46% -49.6%
Cash & Equivalents $2.192B $1.973B
Short-Term Investments $127.0M $185.0M
Other Short-Term Assets $1.095B $1.205B
YoY Change -9.13% 46.42%
Inventory
Prepaid Expenses
Receivables $3.663B $3.232B
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.077B $6.595B
YoY Change 7.31% -20.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.171B $1.250B
YoY Change -6.32% -5.45%
Goodwill $5.605B $5.219B
YoY Change 7.4% 30.02%
Intangibles $1.167B $1.110B
YoY Change 5.14% 10.45%
Long-Term Investments $67.00M $31.00M
YoY Change 116.13% -16.22%
Other Assets $708.0M $760.0M
YoY Change -6.84% -6.06%
Total Long-Term Assets $10.36B $10.07B
YoY Change 2.9% 10.56%
TOTAL ASSETS
Total Short-Term Assets $7.077B $6.595B
Total Long-Term Assets $10.36B $10.07B
Total Assets $17.43B $16.66B
YoY Change 4.65% -4.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $394.0M $349.0M
YoY Change 12.89% 20.76%
Accrued Expenses $1.888B $1.973B
YoY Change -4.31% 25.83%
Deferred Revenue
YoY Change
Short-Term Debt $38.00M $38.00M
YoY Change 0.0% 0.0%
Long-Term Debt Due $38.00M $38.00M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $3.186B $3.150B
YoY Change 1.14% 9.68%
LONG-TERM LIABILITIES
Long-Term Debt $617.0M $654.0M
YoY Change -5.66% -73.09%
Other Long-Term Liabilities $286.0M $334.0M
YoY Change -14.37% 45.85%
Total Long-Term Liabilities $903.0M $988.0M
YoY Change -8.6% -62.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.186B $3.150B
Total Long-Term Liabilities $903.0M $988.0M
Total Liabilities $5.461B $5.623B
YoY Change -2.88% -17.5%
SHAREHOLDERS EQUITY
Retained Earnings $11.96B $10.91B
YoY Change 9.62% 0.7%
Common Stock $5.000M $5.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.97B $11.04B
YoY Change
Total Liabilities & Shareholders Equity $17.43B $16.66B
YoY Change 4.65% -4.41%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $563.0M $505.0M
YoY Change 11.49% 37.6%
Depreciation, Depletion And Amortization $143.0M $141.0M
YoY Change 1.42% 3.68%
Cash From Operating Activities $306.0M $181.0M
YoY Change 69.06% -63.58%
INVESTING ACTIVITIES
Capital Expenditures $120.0M $88.00M
YoY Change 36.36% -21.43%
Acquisitions $0.00 $310.0M
YoY Change -100.0% 260.47%
Other Investing Activities $820.0M -$450.0M
YoY Change -282.22% 181.25%
Cash From Investing Activities $700.0M -$538.0M
YoY Change -230.11% 97.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $474.0M $240.0M
YoY Change 97.5% -53.03%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$600.0M -$340.0M
YoY Change 76.47% -129.96%
NET CHANGE
Cash From Operating Activities $306.0M $181.0M
Cash From Investing Activities $700.0M -$538.0M
Cash From Financing Activities -$600.0M -$340.0M
Net Change In Cash $400.0M -$707.0M
YoY Change -156.58% -156.97%
FREE CASH FLOW
Cash From Operating Activities $306.0M $181.0M
Capital Expenditures $120.0M $88.00M
Free Cash Flow $186.0M $93.00M
YoY Change 100.0% -75.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001058290
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
0-24429
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei City Area Code
CityAreaCode
201
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
801-0233
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3728359
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Frank W. Burr Blvd.
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666
CY2022Q1 dei Trading Symbol
TradingSymbol
CTSH
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
521173838 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2192000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1792000000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
127000000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
927000000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3663000000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3557000000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1095000000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1066000000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
7077000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7342000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1171000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1171000000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
915000000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
933000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
5605000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
5620000000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1167000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1218000000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
333000000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
404000000 USD
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
458000000 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
463000000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
708000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
701000000 USD
CY2022Q1 us-gaap Assets
Assets
17434000000 USD
CY2021Q4 us-gaap Assets
Assets
17852000000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
394000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
361000000 USD
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
455000000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
403000000 USD
CY2022Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
38000000 USD
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
38000000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
194000000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195000000 USD
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2105000000 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2532000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3186000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3529000000 USD
CY2022Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
23000000 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40000000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
758000000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
783000000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
213000000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
218000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
617000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
626000000 USD
CY2022Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
378000000 USD
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
378000000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
286000000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
287000000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
5461000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
5861000000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
521000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
521000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
525000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
525000000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31000000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27000000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11956000000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11922000000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
37000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11973000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11991000000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17434000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17852000000 USD
CY2022Q1 us-gaap Revenues
Revenues
4826000000 USD
CY2021Q1 us-gaap Revenues
Revenues
4401000000 USD
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3097000000 USD
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2764000000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
862000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
827000000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
143000000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
141000000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
724000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
669000000 USD
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
6000000 USD
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
9000000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
2000000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
2000000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
729000000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
665000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
563000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
524000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
530000000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
525000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
531000000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
563000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-37000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-25000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-19000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-4000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
507000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
476000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11991000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
563000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-56000000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
56000000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
470000000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
142000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11973000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10836000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-29000000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000000 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
252000000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
128000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11037000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
563000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
143000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
141000000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
70000000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
122000000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
56000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
62000000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-27000000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
117000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
131000000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
73000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36000000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61000000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
36000000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
15000000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-434000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-558000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
306000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
181000000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
120000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000000 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
65000000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
310000000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2022Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2022Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
16000000 USD
CY2021Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
82000000 USD
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
20000000 USD
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
62000000 USD
CY2022Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
39000000 USD
CY2021Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
150000000 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
591000000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
30000000 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
19000000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
310000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
700000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-538000000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
31000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
43000000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
474000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
240000000 USD
CY2022Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
14000000 USD
CY2021Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
15000000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
143000000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
128000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-600000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-340000000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
400000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-707000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1792000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2680000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2192000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1973000000 USD
CY2021Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4826000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4826000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4826000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4401000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4401000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4401000000 USD
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
394000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
467000000 USD
CY2022Q1 ctsh Capitalized Contract Cost Costs Capitalized
CapitalizedContractCostCostsCapitalized
12000000 USD
CY2021Q1 ctsh Capitalized Contract Cost Costs Capitalized
CapitalizedContractCostCostsCapitalized
14000000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-27000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-29000000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
-9000000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
379000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
443000000 USD
CY2021Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
310000000 USD
CY2020Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
315000000 USD
CY2022Q1 ctsh Contract With Customer Asset Revenue Recognized But Not Billed
ContractWithCustomerAssetRevenueRecognizedButNotBilled
259000000 USD
CY2021Q1 ctsh Contract With Customer Asset Revenue Recognized But Not Billed
ContractWithCustomerAssetRevenueRecognizedButNotBilled
183000000 USD
CY2022Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-202000000 USD
CY2021Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-162000000 USD
CY2022Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
367000000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
67000000 USD
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000 USD
CY2021Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
336000000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
443000000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
419000000 USD
CY2022Q1 ctsh Contract With Customer Liability Amount Billed But Revenue Not Recognized
ContractWithCustomerLiabilityAmountBilledButRevenueNotRecognized
396000000 USD
CY2021Q1 ctsh Contract With Customer Liability Amount Billed But Revenue Not Recognized
ContractWithCustomerLiabilityAmountBilledButRevenueNotRecognized
341000000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-361000000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-325000000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
478000000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
435000000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1720000000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.85
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
50000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
57000000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
63000000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-5000000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6000000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
57000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
46000000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
127000000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
927000000 USD
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
458000000 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
463000000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3000000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1233000000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1601000000 USD
CY2022Q1 ctsh Customer Volumeand Other Incentives Current
CustomerVolumeandOtherIncentivesCurrent
271000000 USD
CY2021Q4 ctsh Customer Volumeand Other Incentives Current
CustomerVolumeandOtherIncentivesCurrent
242000000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57000000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
74000000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
190000000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
220000000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
354000000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
395000000 USD
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2105000000 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2532000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
617000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
626000000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.241
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
48000000 USD
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
5000000 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
69000000 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
7000000 USD
CY2022Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
30000000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
724000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
669000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1171000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1171000000 USD

Files In Submission

Name View Source Status
0001058290-22-000113-index-headers.html Edgar Link pending
0001058290-22-000113-index.html Edgar Link pending
0001058290-22-000113.txt Edgar Link pending
0001058290-22-000113-xbrl.zip Edgar Link pending
ctsh-20220331.htm Edgar Link pending
ctsh-20220331.xsd Edgar Link pending
ctsh-20220331_cal.xml Edgar Link unprocessable
ctsh-20220331_def.xml Edgar Link unprocessable
ctsh-20220331_g1.jpg Edgar Link pending
ctsh-20220331_g10.jpg Edgar Link pending
ctsh-20220331_g11.jpg Edgar Link pending
ctsh-20220331_g12.jpg Edgar Link pending
ctsh-20220331_g13.jpg Edgar Link pending
ctsh-20220331_g14.jpg Edgar Link pending
ctsh-20220331_g15.jpg Edgar Link pending
ctsh-20220331_g16.jpg Edgar Link pending
ctsh-20220331_g17.jpg Edgar Link pending
ctsh-20220331_g18.jpg Edgar Link pending
ctsh-20220331_g19.jpg Edgar Link pending
ctsh-20220331_g2.jpg Edgar Link pending
ctsh-20220331_g20.jpg Edgar Link pending
ctsh-20220331_g21.jpg Edgar Link pending
ctsh-20220331_g3.jpg Edgar Link pending
ctsh-20220331_g4.jpg Edgar Link pending
ctsh-20220331_g5.jpg Edgar Link pending
ctsh-20220331_g6.jpg Edgar Link pending
ctsh-20220331_g7.jpg Edgar Link pending
ctsh-20220331_g8.jpg Edgar Link pending
ctsh-20220331_g9.jpg Edgar Link pending
ctsh-20220331_htm.xml Edgar Link completed
ctsh-20220331_lab.xml Edgar Link unprocessable
ctsh-20220331_pre.xml Edgar Link unprocessable
ctshexhibit3113312022.htm Edgar Link pending
ctshexhibit3123312022.htm Edgar Link pending
ctshexhibit3213312022.htm Edgar Link pending
ctshexhibit3223312022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending